AngioDynamics Inc (FRA:UG2)
€ 6.15 -0.1 (-1.67%) Market Cap: 251.87 Mil Enterprise Value: 205.71 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 66/100

AngioDynamics Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 05:00PM GMT
Release Date Price: €5.4 (-2.70%)
Caroline Borowski JPMorgan Chase;Co.;Moderator

&-

Hi all, my name is Caroline Braskem. I'm part of the healthcare investment banking group here at JPMorgan. It's my pleasure to introduce Jim Clemmer, President, and CEO of AngioDynamics.

Jim Clemmer AngioDynamics
Inc - President, CEO

Thank you, Caroline. And thanks to JPMorgan for a great conference this year. Appreciate the invitation. So let me welcome you to the AngioDynamics presentation. We'll spend the next 20 minutes or so talking about our Company, and I'll be joined by our Executive Vice President and CFO, Steve Trowbridge will take questions.

Let me remind you again what you'll hear today from me are forward looking statements, ideas, strategies and what we're interested in taking our company to provide additional shareholder value over time. I can't guarantee everything will happen on the time line I laid out, we'll do our best to be transparent to each of you during the process.

Into dynamics is a 35 year old company founded to serve the interventional

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot